Skip to main content

Treatment for late-stage prostate cancer patients: getting closer to a solution

Images

Participants

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

The European Research Council (ERC) has devoted an ERC story to Xavier Salvatella, ICREA researcher and head of the Laboratory of Molecular Biophysics. Salvatella holds an ERC Consolidator Grant to study how the protein androgen receptor folds and how mutations in this protein are linked to drug resistance developed in late-stage prostate cancer patients. This research may open the door to new therapies.

The ERC piece includes the "Meet Our Scientists" video devoted to the researcher—the launch of which inspired this European organisation to write this article about him. The aim of the “Meet Our Scientists” series is to promote IRB Barcelona scientists, attract talent, and spread the word about the benefits of biomedical research.

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).